期刊文献+

A multilevel pan-cancer map links gene mutations to cancer hallmarks

A multilevel pan-cancer map links gene mutations to cancer hallmarks
下载PDF
导出
摘要 Background:A central challenge in cancer research is to create models that bridge the gap between the molecular level on which interventions can be designed and the cellular and tissue levels on which the disease phenotypes are manifested.This study was undertaken to construct such a model from functional annotations and explore its use when integrated with large-scale cancer genomics data.Methods:We created a map that connects genes to cancer hallmarks via signaling pathways.We projected gene mutation and focal copy number data from various cancer types onto this map.We performed statistical analyses to uncover mutually exclusive and co-occurring oncogenic aberrations within this topology.Results:Our analysis showed that although the genetic fingerprint of tumor types could be very different,there were less variations at the level of hallmarks,consistent with the idea that different genetic alterations have similar functional outcomes.Additionally,we showed how the multilevel map could help to clarify the role of infrequently mutated genes,and we demonstrated that mutually exclusive gene mutations were more prevalent in pathways,whereas many co-occurring gene mutations were associated with hallmark characteristics.Conclusions:Overlaying this map with gene mutation and focal copy number data from various cancer types makes it possible to investigate the similarities and differences between tumor samples systematically at the levels of not only genes but also pathways and hallmarks. Background:A central challenge in cancer research is to create models that bridge the gap between the molecular level on which interventions can be designed and the cellular and tissue levels on which the disease phenotypes are manifested.This study was undertaken to construct such a model from functional annotations and explore its use when integrated with large-scale cancer genomics data.Methods:We created a map that connects genes to cancer hallmarks via signaling pathways.We projected gene mutation and focal copy number data from various cancer types onto this map.We performed statistical analyses to uncover mutually exclusive and co-occurring oncogenic aberrations within this topology.Results:Our analysis showed that although the genetic fingerprint of tumor types could be very different,there were less variations at the level of hallmarks,consistent with the idea that different genetic alterations have similar functional outcomes.Additionally,we showed how the multilevel map could help to clarify the role of infrequently mutated genes,and we demonstrated that mutually exclusive gene mutations were more prevalent in pathways,whereas many co-occurring gene mutations were associated with hallmark characteristics.Conclusions:Overlaying this map with gene mutation and focal copy number data from various cancer types makes it possible to investigate the similarities and differences between tumor samples systematically at the levels of not only genes but also pathways and hallmarks.
出处 《Chinese Journal of Cancer》 SCIE CAS CSCD 2015年第10期439-449,共11页
基金 supported in part by the National Cancer Institute (U24CA143835 to IS and TAK) the Netherlands Organization for Scientific Research-The Cancer System Biology Center(to LFAW and TB)
关键词 CANCER systems biology CANCER hallmarks Gene mutations MULTILEVEL model Cancer systems biology Cancer hallmarks Gene mutations Multilevel model
  • 相关文献

参考文献23

  • 1Marusyk A, Polyak K. Tumor heterogeneity: causes and consequences.Biochim Biophys Acta. 2010;1805(1):105–17.
  • 2Longo DL. Tumor heterogeneity and personalized medicine. N Engl JMed. 2012;366(10):956-7.
  • 3Hanahan D, Coussens LM. Accessories to the crime: functions of cellsrecruited to the tumor microenvironment. Cancer Cell. 2012;21(3):309-22.
  • 4Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators ofthe tumor microenvironment. Cell. 2010;141(1):52-67.
  • 5van't Veer LJ. Bernards R. Enabling personalized cancer medicine throughanalysis of gene-expression patterns. Nature. 2008;452(7187):564-70.
  • 6Hamburg MA, Collins FS. The path to personalized medicine. N Engl JMed. 2010;363(4):301-4.
  • 7Hood L, Friend SH. Predictive, personalized, preventive, participatory (P4)cancer medicine. Nat Rev Clin Oncol. 2011;8(3):184-7.
  • 8Hanahan D, Weinberg RA. The hallmarks of cancer. Cell.2000;100(1):57-70.
  • 9Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell.2011;144(5):646-74.
  • 10Leiserson MD, Vandin F, Wu HT, Dobson JR, Eldridge JV, Thomas JL,et al. Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes. Nat Genet.2015;47(2):106-14.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部